Bioequivalence test for Olmesartan medoxomil plus Hydrochlorothiazide

Kyung Hee University Hospital0 个研究点目标入组 44 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1. Subject is male and aged between 19 and 55 years of age (inclusive)
•2. Subject has no clinically relevant findings in the physical examination (as judged by the investigator)
•3. Subject has no clinically relevant abnormality in the clinical chemistry, hematology, or urinalysis

•1. Subject is taking any inducers and inhibitors on drug-metabolizing enzymes (such as barbital)within 1 month.
•2. Subject is taking any medication (excluding oral hormonal contraceptive) currently or within 10 days prior to the first day of dosing
•3. Subject has a clinically relevant allergy (including the study drug)
•4. Subject has a history of significant hypersensitivity (or allergy) to study drug
•5. Subject has participated in another clinical trial of an investigational drug within the last 3 months
•6. Suject has had a history of transient ischemic attack or stroke within the last 12 months
•7. Subject is unable to read or write
•8. Subject have genetic disorders (galatose intolerance, Lapp lactase deficiency, glucose-galatose malabsorption etc.)

发起方

Kyung Hee University Hospital